ELCEVEVE Trademark

Trademark Overview

On Tuesday, October 21, 2014, a trademark application was filed for ELCEVEVE with the United States Patent and Trademark Office. The USPTO has given the ELCEVEVE trademark a serial number of 86430032. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 9, 2018. This trademark is owned by Eli Lilly and Company. The ELCEVEVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
elceveve

General Information

Serial Number86430032
Word MarkELCEVEVE
Filing DateTuesday, October 21, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 9, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Translation of Words in MarkThe wording "ELCEVEVE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 29, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, July 9, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 9, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 24, 2017EXTENSION 5 GRANTED
Tuesday, November 21, 2017EXTENSION 5 FILED
Tuesday, November 21, 2017TEAS EXTENSION RECEIVED
Friday, June 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2017EXTENSION 4 GRANTED
Tuesday, May 30, 2017EXTENSION 4 FILED
Wednesday, June 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 30, 2017TEAS EXTENSION RECEIVED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 17, 2016EXTENSION 3 GRANTED
Tuesday, November 22, 2016EXTENSION 3 FILED
Tuesday, November 22, 2016TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 30, 2016EXTENSION 2 GRANTED
Friday, March 25, 2016EXTENSION 2 FILED
Sunday, April 24, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 25, 2016TEAS EXTENSION RECEIVED
Friday, October 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2015EXTENSION 1 GRANTED
Friday, September 25, 2015EXTENSION 1 FILED
Thursday, October 1, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 25, 2015TEAS EXTENSION RECEIVED
Tuesday, June 2, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 2, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 2, 2015ASSIGNED TO LIE
Monday, February 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 9, 2015EXAMINER'S AMENDMENT ENTERED
Monday, February 9, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 9, 2015EXAMINERS AMENDMENT E-MAILED
Monday, February 9, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, February 9, 2015ASSIGNED TO EXAMINER
Wednesday, October 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 24, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

elceveve disorders diseases preparations diagnostic pharmaceutical neurodegenerative neurological pain parkinson liver